| |
| |
|
| Insider
Information: |
Craves Fred B |
| Relationship: |
Director |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
850,103 |
|
|
Indirect Shares
|
576,605 |
|
|
| Direct
Value |
$100,959,500 |
|
|
|
Indirect Value
|
$18,349,138 |
|
|
| Total
Shares |
1,426,708 |
|
|
| Total
Value |
$119,308,638 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 64.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Incyte Corp |
INCY |
Director |
2004-04-21 |
196,793 |
2004-04-21 |
31,200 |
Premium* |
|
|
Poniard Pharmaceuticals |
PARD |
Director |
2011-06-09 |
239,948 |
2011-06-09 |
402,311 |
Premium* |
|
|
Madrigal Pharmaceuticals Inc |
MDGL |
|
2024-05-14 |
413,362 |
2024-05-14 |
76,323 |
Premium* |
|
|
Twist Bioscience Corp |
TWST |
Director |
2018-11-02 |
0 |
2018-11-02 |
66,771 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
40 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| INCY |
Incyte Corp |
Director |
– • – |
2004-04-21 |
4 |
A |
$0.00 |
$0 |
D/D |
56,793 |
196,793 |
|
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • • |
2016-07-22 |
4 |
A |
$0.00 |
$0 |
I/I |
5,657,854 |
119,380 |
0 |
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • • |
2016-07-22 |
4 |
A |
$0.00 |
$0 |
D/D |
296,067 |
296,067 |
0 |
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • • |
2018-06-11 |
4 |
S |
$287.46 |
$1,698,314 |
I/I |
(5,908) |
113,472 |
0 |
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • • |
2018-06-11 |
4 |
S |
$287.46 |
$78,790,486 |
I/I |
(274,092) |
5,264,382 |
0 |
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • • |
2018-11-19 |
4 |
B |
$123.17 |
$249,387 |
D/D |
2,000 |
298,067 |
3.92 |
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • • |
2019-12-13 |
4 |
S |
$105.47 |
$126,564,000 |
I/I |
(1,200,000) |
88,152 |
0 |
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • • |
2020-05-27 |
4 |
D |
$0.00 |
$0 |
I/I |
(412,236) |
72,875 |
0 |
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • • |
2020-08-17 |
4 |
S |
$110.73 |
$1,384,125 |
I/I |
(12,500) |
60,375 |
0 |
% |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • • |
2020-08-18 |
4 |
S |
$110.03 |
$1,121,976 |
I/I |
(10,197) |
50,178 |
0 |
% |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • • |
2020-08-19 |
4 |
S |
$107.64 |
$786,095 |
I/I |
(7,303) |
42,875 |
0 |
% |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • • |
2020-09-04 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,545,460) |
43,537 |
0 |
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • • |
2021-12-03 |
4 |
D |
$0.00 |
$0 |
I/I |
(824,172) |
1,261 |
0 |
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • – |
2023-01-30 |
4 |
GD |
$0.00 |
$0 |
I/I |
3,557 |
57,062 |
0 |
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • – |
2023-12-07 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,556,594) |
1,261 |
0 |
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
|
– • – |
2024-05-14 |
4 |
AS |
$210.99 |
$4,787,404 |
D/D |
(22,489) |
413,362 |
0 |
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
|
– • – |
2024-05-14 |
4 |
OE |
$100.45 |
$2,316,844 |
D/D |
22,489 |
435,851 |
0 |
- |
|
| PARD |
Poniard Pharmaceuticals |
Director |
– • – |
2004-04-21 |
4 |
A |
$0.00 |
$0 |
D/D |
93,622 |
243,622 |
|
- |
|
| PARD |
Poniard Pharmaceuticals |
Director |
– • – |
2006-04-26 |
4 |
OE |
$0.70 |
$71,827 |
I/I |
102,610 |
102,610 |
|
- |
|
| PARD |
Poniard Pharmaceuticals |
Director |
– • – |
2006-04-26 |
4 |
B |
$0.70 |
$1,254,438 |
I/I |
1,792,054 |
1,894,664 |
2.1 |
- |
|
| PARD |
Poniard Pharmaceuticals |
Director |
– • – |
2007-04-30 |
4 |
B |
$6.33 |
$503,222 |
I/I |
79,498 |
6,407 |
2.1 |
- |
|
| PARD |
Poniard Pharmaceuticals |
Director |
– • – |
2007-08-10 |
4 |
B |
$5.50 |
$5,346 |
I/I |
972 |
6,423 |
2.1 |
- |
|
| PARD |
Poniard Pharmaceuticals |
Director |
– • – |
2007-08-14 |
4 |
B |
$5.50 |
$226 |
I/I |
41 |
6,424 |
2.02 |
- |
|
| PARD |
Poniard Pharmaceuticals |
Director |
– • – |
2007-08-16 |
4 |
B |
$5.48 |
$1,793 |
I/I |
327 |
6,429 |
2.02 |
- |
|
| PARD |
Poniard Pharmaceuticals |
Director |
– • – |
2007-08-29 |
4 |
B |
$5.75 |
$2,023 |
I/I |
352 |
6,435 |
2.02 |
- |
|
40 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
